跳至主要内容
临床试验/NCT07568470
NCT07568470Enrolling By Invitation不适用

Elicitation of the Phoenix Sign With Non-guided Subcutaneous D5W Infiltration

US Neuropathy Centers1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2026年4月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
600
试验地点
1

研究概览

简要总结

To determine if the Phoenix sign can be reliably elicited with non-guided subcutaneous infiltration of D5W (5% Dextrose in Water) in patients with subclinical weakness of the extensor hallucis longus (EHL) muscle.

详细描述

  • To determine the prevalence of subclinical EHL weakness in a general clinical population
  • To measure the time course of strength changes following D5W infiltration
  • To identify potential predictive factors for positive response to treatment

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Sequential
主要目的
Diagnostic
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • subjects must have a weakness of dorsiflexion and specifically of the Extensor Hallucis Longus muscle
  • drop foot

排除标准

  • Trypanaphobia
  • allergy to D5W

研究组 & 干预措施

Infiltration of D5W

Experimental

3 cc's of D5W will be infiltrated subcutaneously at the level of the fibular neck to see if there is any improvement in dorsiflexion strength at 4 and 10 minutes post infiltration.

干预措施: Infiltration of D5W (Drug)

研究者

发起方
US Neuropathy Centers
申办方类型
Other
责任方
Principal Investigator
主要研究者

Stephen Barrett

Principle Investigator

US Neuropathy Centers

研究点 (1)

Loading locations...

相似试验